key: cord-0802297-c4ik8adl
authors: Cesarz, Joseph L; Mott, David A; Friestrom, Eric D
title: A framework for graduate and postgraduate specialty pharmacy training
date: 2021-03-10
journal: Am J Health Syst Pharm
DOI: 10.1093/ajhp/zxab086
sha: 8710db30ac9bf1570b78f32b219c18564b55b4c5
doc_id: 802297
cord_uid: c4ik8adl

DISCLAIMER: In an effort to expedite the publication of articles related to the COVID-19 pandemic, AJHP is posting these manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time. PURPOSE: There is a growing need for specialty pharmacy leaders within integrated delivery networks (IDNs). Traditional training for students and residents has not met the demand for pharmacy leaders in this space. This article describes the partnership between UW Health (UWH) and the University of Wisconsin School of Pharmacy (UWSOP) in developing a specialty pharmacy elective course at UWSOP and in creating a postgraduate residency training program at UWH. Future directions for the partnership are discussed. SUMMARY: Members of the leaderships of UWH and UWSOP met to discuss expanding coursework related to specialty pharmacy business fundamentals at UWSOP. This meeting led to the development of a 2-credit elective course beginning in spring 2017. The course focused on marketplace economics, channel strategies, and specialty pharmacy practice development. Additionally, UWH identified the need to provide postgraduate training to meet the increasing demand across IDNs for specialty pharmacy leaders. The residency program was initiated in 2013 and received accreditation in 2016. The residency provides experience in specialty pharmacy leadership, managed care, finance, the revenue cycle, accreditation, and the supply chain. Future partnership opportunities include creation of a longitudinal student pharmacist track and joint project coordination between UWSOP students and UWH residents. CONCLUSION: This partnership has provided a pathway for students to gain expertise in specialty pharmacy business fundamentals as well as postgraduate training opportunities for future specialty pharmacy leaders. IDN and school of pharmacy partnerships can expand educational opportunities for future specialty pharmacy leaders and help fulfill the market gap in specialty pharmacy leaders.

A c c e p t e d M a n u s c r i p t Am J Health-Syst Pharm. 2021;78(x):xxx-xxx Over the last 10 years, specialty medications have substantially increased the overall healthcare drug spend. The quantity of specialty medications in the market, patient utilization of specialty pharmaceuticals, and drug pricing have all seen annual increases. [1] [2] [3] With an overwhelming majority of agents in the drug pipeline being specialty medications, this trend shows no signs of stopping. It is estimated that specialty medications account for approximately 45% of the overall $450 billion market. 4 With this growth in specialty medication volume and cost, unique drug channels and competitive marketplaces have emerged, requiring pharmacy leaders to be trained and competent in this area. Due to the complicated and cumbersome processes faced by many patients initiated on specialty medications, integrated delivery networks (IDNs) have gained interest as a means of providing specialty pharmacy services that promotes a better patient experience and improved clinical outcomes. This has led to an increased need at IDNs for pharmacy leaders who understand health-system enterprise economics and the specialty pharmacy marketplace. Core competencies include streamlining prior authorization procedures, establishing logistics to deliver specialty medications, achieving and maintaining appropriate accreditation(s), collaborating with specialty prescribers, and developing procedures to increase the rate of capture of specialty medication prescriptions from clinics. UW Health (UWH) has managed patients with specialty disease states for decades and formally started specialty pharmacy services in 2012. The specialty pharmacy serves over 80 clinics and provides care to approximately 6,600 patient lives. The specialty pharmacy is triple-accredited by URAC (since 2017), the Center for Pharmacy Practice Accreditation (since 2017), and the Accreditation Commission for Health Care (since 2019), A c c e p t e d M a n u s c r i p t and all specialty pharmacists have earned the Certified Specialty Pharmacist (CSP) credential through the National Association of Specialty Pharmacy. Due to the significance of specialty pharmacy to UWH and the ongoing need to develop competent clinicians and leaders in this area, a strategic effort was made to increase training and educational opportunities in specialty pharmacy for student pharmacists and pharmacy residents. Cornerstones of this effort were establishing a partnership between the UWH pharmacy department and the University of Wisconsin School of Pharmacy (UWSOP) and initiating an ASHP-accredited specialty pharmacy residency.

The purpose of this article is to highlight the partnership between UWH and UWSOP to enhance training and educational opportunities in specialty pharmacy leadership and to describe the implementation of a UWH postgraduate residency training program. Future directions for the partnership related to specialty pharmacy training are also described. For reference, a timeline of key events is provided in Figure 1 to outline the chronology of the programs developed to enhance training and educational opportunities in specialty pharmacy.

The conception of UWSOP training opportunities related to specialty pharmacy originated in discussions between pharmacy leadership team members, including the senior director of pharmacy, director of ambulatory services, and the manager of specialty pharmacy at UWH, an assistant director for clinical program development at another IDN, and the chairpersons of the Pharmacy Practice Division and the Social and Administrative Sciences (SAS) Division at UWSOP. The objectives were to discuss the need for additional specialty pharmacy educational offerings at UWSOP and identify core concepts to include in A c c e p t e d M a n u s c r i p t the coursework. Members of the group from the 2 IDNs identified that students needed training related to marketplace economics, supply chain strategies (including the 340B Drug Pricing Program), business integrity, reimbursement, and pharmacy practice development.

Further, they noted that specialty pharmacy was experiencing significant growth regionally and nationally, and that there will be a continued need for pharmacists to develop and manage services in this area. Additionally, their observations showed that student pharmacists and incoming postgraduate year 1 (PGY1) pharmacy residents lacked awareness of business fundamentals related to specialty pharmacy, the implications and importance of specialty pharmacy for pharmacy practice, and the growth potential of specialty pharmacy.

Members of the group from UWSOP shared that the preexisting curriculum did not effectively prepare students to navigate future challenges related to specialty pharmacy that they may encounter. While the group felt that clinical aspects of many specialty drugs (ie, mechanisms of action, indications, dosing, and monitoring) were effectively covered in the second and third years of the required curriculum, there was limited faculty experience and student exposure to specialty pharmacy economics and business management. The concepts of drug distribution channels and pharmacoeconomics were provided to students in the first year of the PharmD curriculum, but at this point many students had little context for these subjects and there was no direct application to specialty pharmacy thereafter.

However, UWSOP leaders shared that UWSOP offered introductory pharmacy practice experiences (IPPEs) and Advanced pharmacy practice experiences (APPEs) at specialty pharmacy practice sites in the second half of the PharmD curriculum.

Based on the information shared by both groups, planning for a 2-credit elective course focused on specialty pharmacy that would be offered to third-year doctor of A c c e p t e d M a n u s c r i p t pharmacy students began. The group first determined the overall objectives of the course, the outline of topics and objectives for each topic, the proper mix of faculty and specialty pharmacy practitioners who would provide the content, and the format to be used to provide the content. The group identified a faculty member to coordinate the course and provide course content. Additionally, the group developed a list of local UWSOP alumni who were practicing in specialty pharmacy and/or had expertise in an area applicable to the goals of the course. These experts were then contacted to gauge their interest in providing content for the course based on his or her area of expertise. The entire planning process took 9 months to complete. The course was first offered in the spring 2016 semester and continues to be offered, with the most recent semester occurring in the spring of 2020. Table 1 lists the topics covered, the providers of the topic content, and the objectives for each weekly meeting of the 16-week, semester-long course. One week of the semester is allocated to spring break and 1 week is allocated to school-wide testing of thirdyear students. The course is coordinated by a faculty member in the SAS division.

Enrollment in the course is limited to 20 to 25 students to facilitate class discussion. Students are provided with reading material for each class session that consists of industry reports, academic research articles, specialty pharmacy trade press articles, and newspaper articles. Students are required to read the provided materials prior to each weekly meeting and to submit to the course coordinator before the meeting up to 3 questions they have about the topic. The students' questions are shared with the topic leader for the corresponding week. Students submit structured reflections on weekly topics, which allows for assessment of their learning and understanding of key topics.

In 2012, UWH was experiencing significant growth in specialty pharmacy volumes, and discussions with other IDN pharmacy leaders made it evident that this was a shared trend. Due to improved patient care, clinic staff satisfaction, and financial benefit, many health systems were developing internal specialty pharmacy programs. [5] [6] [7] However, a specialty pharmacy program was a relatively new business unit for IDNs, and there was a significant need for cultivating pharmacy leaders in the specialty pharmacy space. As a result, UWH began developing a postgraduate training program to develop future specialty pharmacy leaders.

The conceptual framework for the program was established with input from the department leadership and guidance from experienced residency program directors (RPDs) at UWH. The director of ambulatory pharmacy services was enlisted to serve as the RPD for the Specialty Pharmacy Program. An application for pre-candidate status was submitted to ASHP, and the first resident was matched with and started the program in July 2013.

The initial structure of the program was a combined PGY1 and postgraduate year 2 (PGY2) program. The PGY1 year was highly integrated with a UWH PGY1 pharmacy practice Additionally, UWH and UWSOP are planning to partner on major resident research projects to improve project frameworks, scholarship, and collaboration between clinicians, leaders, and researchers. This will transform the existing project and research enterprise in both entities, resulting in improvements for all engaged participants. Residents will achieve improved access to seasoned researchers, experience with grant proposals, training in highintegrity project frameworks, and more facets of scholarship. Leaders and clinicians will receive opportunities for professional development related to formal research, improved preceptorship for future projects, and better engagement in scholarly activities. Researchers will have access to experts in pharmacy practice and leadership, allowing for a better understanding of contemporary issues, unanswered questions in daily practice, and more impactful opportunities for future research. This type of translational research framework is crucial in a growing area like specialty pharmacy, where there is scarcity of research in practice management and clinical outcomes and the need for the results of such research is growing.

A c c e p t e d M a n u s c r i p t

Specialty pharmacy is, and will continue to be, an important area for pharmacist leadership within IDNs. The partnership between UWH and UWSOP serves as a model of collaboration between IDNs and schools of pharmacy to increase student awareness of specialty pharmacy and provide resident teaching opportunities. By providing these experiences, UWH is helping to prepare students and trainees to be qualified for specialty leadership roles after training. This collaboration has also provided an opportunity for differentiation of UWSOP from other schools of pharmacy. Students at UWSOP can gain exposure to specialty pharmacy, an area with an anticipated increase in demand for the foreseeable future. We encourage all IDNs and schools of pharmacy to form specialty pharmacy-focused collaborations and consider the implementation or expansion of specialty pharmacy student courses and accredited residencies M a n u s c r i p t M a n u s c r i p t M a n u s c r i p t

 Specialty pharmacy leadership roles will be increasingly critical to successfully manage health-system pharmacy departments.

 Collaboration between integrated delivery networks (IDNs) and schools of pharmacies increases student awareness of specialty pharmacy and helps prepare learners for career opportunities in specialty pharmacy.

 Other IDNs and schools of pharmacy are encouraged to explore partnerships in specialty pharmacy training and should consider the addition of curriculum and residency training opportunities in this area.

M a n u s c r i p t Course coordinator 1. Identify characteristics of drug products that define drug products as specialty drug products. 2. Describe significant trends in specialty drug spending, price and utilization. Describe the implications of these trends for the health system. 3. Describe the components of the channel of distribution of patient administered specialty drug products. 4. Describe how characteristics of specialty drug products impact the goals and objectives of components in the channel of distribution for specialty drugs. 5. Describe the implications of characteristics of specialty drug products for specialty pharmacy operations. 6. Link characteristics of the specialty pharmacy market to future class topics. Set stage for class topics. 2 Specialty Pharmacy Operations, Distribution, and Infrastructure

Behind the numbers 2020

National trends in prescription drug expenditures and projections for 2019

The evolution of specialty management: spending growth spurs innovation but are all models equal? CVS Health Payor Solutions

Medicine use and spending in the U.S.: a review of 2018 and outlook to 2023

Advancing patient care through specialty pharmacy services in an academic health system

Integrated clinical and specialty pharmacy practice model for management of patients with multiple sclerosis

Integrated specialty pharmacy yields high PCSK9 inhibitor access and initiation rates

M a n u s c r i p t Panel of pharmacists from 2 IDNs and a retail specialty pharmacy 1. Compare and contrast different models of specialty pharmacy development. 2. Describe core services of specialty pharmacy operations and patients served. 3 . Describe infrastructure requirements of specialty pharmacy services development 4. Describe the relationship between specialty pharmacy, health providers, and the health plan within an IDN. 5. Describe future strategic directions for specialty pharmacies. 3 Pharmacy Benefit Managers (PBMs) Course coordinator 1. Discuss the role of PBMs in the health care system. Describe the services that PBMs offer various entities in the health care system. 2. Provide a brief history of PBMs in the health care market and how their role has evolved to their role today. 3 . Describe the money flow and physical product flow through PBMs in the healthcare system.A c c e p t e d M a n u s c r i p t 4 . Discuss the role of PBMs in the specialty pharmacy channel of distribution. 5. Compare and contrast common models of PBMs in the marketplace. 6 A c c e p t e d M a n u s c r i p t A c c e p t e d M a n u s c r i p t